Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1995-6-20
|
| pubmed:abstractText |
Well-differentiated thyroid cancer is the most common malignancy of the thyroid gland, yet its optimal management remains controversial. 269 patients with such lesions were operated on, with or without supplementary treatment. It was concluded that young patients with stage I disease can be safely treated by subtotal thyroidectomy. Total thyroidectomy combined with radioactive ablation is indicated in patients with more advanced systemic disease.
|
| pubmed:language |
heb
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0017-7768
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
128
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
340-8, 400
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1995
|
| pubmed:articleTitle |
[Treatment of well-differentiated thyroid cancer].
|
| pubmed:affiliation |
Surgical Dept., Hadassah University Hospital, Jerusalem.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|